FDA Greenlights “The Little Pink Pill”
The Food and Drug Administration is giving the green light to a drug that treats low sex drive in women. Known as the "little pink pill," flibanserin has been approved and will be marketed under the name Addyi. Maker Sprout Pharmaceuticals says the drug will likely be available by October 17th. Critics say the drug has risky side effects.
According to vox.com, here are a few of the alleged many side effects:
- Drowsiness, dizziness, and fainting, which increased the risk of injuries such as concussions. Extremely low blood pressure was another less common side effect.
- Side effects are exacerbated when the drug is taken with alcohol and hormonal contraceptives — and many, many women drink alcohol and use these types of birth control.
Not all doctors will be initially allowed to prescribe this medication. The FDA is requiring additional training for doctors before they can write prescriptions for this.
More From WRRV-WRRB
